At a glance
ClinicalIndex Comparison RecordN/ACompleted· 205 enrolled
Drug / intervention
Sculptradevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Multi-center, Evaluator-blinded, No-treatment Controlled Study to Evaluate the Effectiveness and Safety of Sculptra for Correction of Midface Volume Deficit and/or Midface Contour Deficiency
In Brief
A clinical study evaluating Sculptra for Midface Volume Deficit. Completed, enrolled 205 participants across 6 sites.
Detailed Summary
This is a randomized, evaluator-blinded, no-treatment controlled study in participants with Midface Volume Deficit and/or Midface Contour Deficiency.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMidface Volume Deficit
CountriesChina
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedOct 2019
Enrollment StartNov 2019
Primary CompletionJul 2021
Study CompletionJul 2022
TodayJul 2026
First PostedOct 18, 2019
Enrollment StartNov 12, 2019
Primary CompletionJul 18, 2021
Study CompletionJul 18, 2022
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 6.7 years ago
Interventions
Sculptradevice
Initial injection and optional 3 injections with Sculptra in Midface.